Notable companies
The most notable companies in this group are Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Regeneron Pharmaceuticals (NASDAQ:REGN), McKesson Corp (NYSE:MCK), Centene Corp (NYSE:CNC), Exelixis (NASDAQ:EXEL).
Industry description
The investment seeks long-term capital growth.
The fund invests primarily in common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. It will invest at least 80% of its net assets, under normal circumstances, in equity securities of health science companies. The fund invests primarily in common stocks of U.S. companies, but may, to a lesser extent, invest in equity REITs, common stocks of foreign companies and American Depositary Receipts ("ADRs") that meet the investment criteria of the fund.
Market Cap
The average market capitalization across the Live Oak Health Sciences MF is 75.63B. The market cap for tickers in the group ranges from 6.69B to 151.69B. AMGN holds the highest valuation in this group at 151.69B. The lowest valued company is EXEL at 6.69B.
Volume
The average weekly volume growth across all stocks in the Live Oak Health Sciences MF was 13%. For the same stocks of the MF, the average monthly volume growth was 20% and the average quarterly volume growth was 37%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 64
P/E Growth Rating: 47
Price Growth Rating: 43
SMR Rating: 55
Profit Risk Rating: 19
Seasonality Score: -4 (-100 ... +100)